Barentz, a leading global specialty ingredients solutions provider, has entered into discussions to acquire 100% equity of Fengli Group, one of the market-leading specialty chemicals distributors for pharmaceutical excipients and active ingredients in China. The strategic move would grant Barentz access to the Chinese pharma market and establish a robust sales network centered around innovative excipients and active pharma ingredients (APIs). The partnership would further enhance the service ...